Cubist Systematic Strategies, LLC I Bio, Inc. Transaction History

Cubist Systematic Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.23 - $0.46 $4,614 - $9,229	20,064 New	20,064 $5,000
Q3 2021 Nov 15, 2021	SELL	$1.06 - $1.52 $17,513 - $25,113	-16,522 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.22 - $1.65 $27,181 - $36,762	-22,280 Reduced 57.42%	16,522 $25,000
Q1 2021 May 17, 2021	BUY	$1.18 - $2.62 $45,786 - $101,661	38,802 New	38,802 $60,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.8M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.